Literature DB >> 2107882

Serine-proline replacement at residue 127 of NADH-cytochrome b5 reductase causes hereditary methemoglobinemia, generalized type.

Y Kobayashi1, Y Fukumaki, T Yubisui, J Inoue, Y Sakaki.   

Abstract

Hereditary methemoglobinemia is an autosomal recessive disorder characterized by NADH-cytochrome b5 reductase (b5R) deficiency. In an attempt to clarify the molecular mechanisms involved in the enzyme deficiency, we isolated the b5R gene from a patient homozygous for hereditary methemoglobinemia, generalized type, and compared its nucleotide sequence with that of the normal NADH-cytochrome b5R gene. Only one difference was observed; a thymidine at the first position of codon 127 (TCT) was altered to a cytidine in the b5R gene of the patient, resulting in replacement of serine with proline. Dot blot hybridization of the amplified DNA samples with allele-specific oligonucleotide probes showed that the proband and her brothers were homozygous for this mutation and that their father was heterozygous. Although the activity of b5R in lymphoblastoid cells from homozygotes was reduced to 10% of the normal level, RNA blot and protein blot analyses of the lymphoblastoid cells showed that synthesis of b5R messenger RNA and the b5R polypeptide were normal. Serine at residue 127 is presumed to be in an alpha-helix structure that is part of a nucleotide-binding domain. These observations suggest that replacement of Pro-127 causes a significant conformation change in the nucleotide-binding domain that affects electron transport from NADH to cytochrome b5. Functional enzyme deficiency results in a generalized type of hereditary methemoglobinemia.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2107882

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  7 in total

1.  Congenital methaemoglobinaemia diagnosed in an adolescent boy.

Authors:  Amal Paul; Sujith Thomas Chacko
Journal:  BMJ Case Rep       Date:  2019-03-31

2.  A splicing mutation in the cytochrome b5 gene from a patient with congenital methemoglobinemia and pseudohermaphrodism.

Authors:  S J Giordano; A Kaftory; A W Steggles
Journal:  Hum Genet       Date:  1994-05       Impact factor: 4.132

3.  Recessive congenital methemoglobinemia type II: Hypoplastic basal ganglia in two siblings with a novel mutation of the cytochrome b5 reductase gene.

Authors:  Manal Nicolas-Jilwan
Journal:  Neuroradiol J       Date:  2019-01-07

4.  Exonic point mutations in NADH-cytochrome B5 reductase genes of homozygotes for hereditary methemoglobinemia, types I and III: putative mechanisms of tissue-dependent enzyme deficiency.

Authors:  T Katsube; N Sakamoto; Y Kobayashi; R Seki; M Hirano; K Tanishima; A Tomoda; E Takazakura; T Yubisui; M Takeshita
Journal:  Am J Hum Genet       Date:  1991-04       Impact factor: 11.025

5.  A single mRNA, transcribed from an alternative, erythroid-specific, promoter, codes for two non-myristylated forms of NADH-cytochrome b5 reductase.

Authors:  G Pietrini; D Aggujaro; P Carrera; J Malyszko; A Vitale; N Borgese
Journal:  J Cell Biol       Date:  1992-06       Impact factor: 10.539

6.  Neurological and Neuroimaging Features of CYB5R3-Related Recessive Hereditary Methemoglobinemia Type II.

Authors:  Francesco Nicita; Letizia Sabatini; Viola Alesi; Giulia Lucignani; Ester Sallicandro; Antonella Sferra; Enrico Bertini; Ginevra Zanni; Giuseppe Palumbo
Journal:  Brain Sci       Date:  2022-01-29

7.  Congenital methemoglobinemia type II in a 5-year-old boy.

Authors:  Elizabeth A Mannino; Thomas Pluim; Jacob Wessler; Megan T Cho; Jane Juusola; Samantha A Schrier Vergano
Journal:  Clin Case Rep       Date:  2017-12-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.